The Bethesda System for Reporting Thyroid Cytopathology: Updates from the New 3rd Edition

Course overview

The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) is the most frequently used cytology reporting system for thyroid FNAs worldwide, with the new updated 3rd edition set to be published in the summer of 2023.The new edition will reflect state-of-the-art practice based on published studies since the 2nd edition, as reviewed by an expanded author list including experts from around the globe. New chapters in this edition will cover Clinical Perspectives and Imaging Studies, as well as Molecular and Ancillary Testing. This webinar will provide an overview of the relevant revisions and updates for the cytology community. Paul VanderLaan, MD, PhD Director of Cytopathology Beth Israel Deaconess Medical Center Associate Professor of Pathology Harvard Medical School Boston, Massachusetts